by the Cierny-Mader classification system for osteomyelitis, which considers both the severity of the infection and host immune status to select surgical treatment strategies 9 . A major barrier to incorporating SSI risk assessment into clinical practice for joint-replacement surgeons is the lack of a method of determining infection risk preoperatively. Specifically, although multivariate regression methods have been used to study independent SSI risk factors after total joint arthroplasty [10] [11] [12] [13] [14] [15] [16] [17] [18] , we are not aware of a current prediction model that can estimate SSI risk after total joint arthroplasty on the basis of preoperative data alone. Current SSI risk assessments rely on factors that are not appropriate or include variables that cannot be measured preoperatively; for example, 2 of 3 variables from the National Nosocomial Infections Surveillance System (NNIS) risk index are the performance of the operation in a contaminated field and an extended operative time compared with similar surgeries 17 . This is despite multiple examples in the literature of preoperative risk factors, including increased body mass index (BMI) 2, 19, 20 , diabetes 2,18 tobacco abuse 14 , malnutrition 21 , inflammatory arthropathy 15 , malignancy 13 , previous SSI 12, 16 , and coagulopathy 13 . The reporting of such risk factors suggests that the construction of a preoperative SSI prediction model for joint arthroplasty is feasible.
Our objective was to create an SSI prediction model for primary or revision knee and hip arthroplasty by utilizing readily available preoperative variables, including demographic information and medical history. We hypothesized that a model created from these data will have some capability of predicting SSI risk. Such a prediction model could be utilized to identify patients at high risk for SSI and allow the surgeon to provide appropriate counseling for risk modification or nonoperative treatment.
Materials and Methods

Data Sources
I nstitutional review board (IRB) approval was obtained for this study. All patients included in the study (n = 6,789; 240 with SSI and 6,549 controls) underwent primary total hip (n = 2,920), primary total knee (n = 2,719), revision total hip (n = 652), or revision total knee arthroplasty (n = 498) at a large academic medical center in the Midwestern United States from January 2000 to October 2011. In the case of multiple hip or knee arthroplasties in the same patient, only the initial surgery was included in the data set to ensure that all observations were independent. Therefore, from an initial total of 9,218 surgeries, we excluded 2,429 primary arthroplasties for a different joint or revision arthroplasties in patients already included; the revisions that were included in the data set were revisions of primary arthroplasties that had been performed at our institution before 2000 and revisions of primary arthroplasties performed at other institutions at any date up to October 2011. Medical record data were obtained from a series of queries to the Information Warehouse (a department in our institution chartered to provide patient data sets to researchers, limited to a given IRB-approved study) and included all total joint arthroplasty surgeries, hospitalizations, and International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes from 1982 to 1524 *Points were assigned on the basis of the risk-factor b coefficient in the multivariate logistic regression model. The smallest coefficient (diabetes, b = 0.183) was assigned 1 point, and each other covariate was assigned a score rounded to the nearest half-point by dividing its coefficient by 0.183. †Likelihood-ratio chi-square test. ‡Insulin dependence was included despite a p value of >0.05 because it was a strong confounder of the overall association of diabetes with infection risk. Insulin-dependent diabetes is assigned 2.5 points total (1 point for the general diagnosis of diabetes, and 1.5 points for insulin dependence). Non-insulin-dependent diabetes is assigned 1 point total.
1526 Medical diagnoses were defined by the presence of a related ICD-9 diagnosis code and by the first date in which the code appeared in a patient's medical record, resulting in a binary variable (for example, diabetic or nondiabetic) and the duration of time between the diagnosis and the date of surgery (for example, 1,047 days). Weight and BMI were defined by measurements obtained on admission for total joint arthroplasty; in the event of missing data, the most recent weight and height were used. In the case of repeat laboratory data (for example, multiple CBCs over several years), the most recent laboratory value prior to surgery was utilized.
Statistical Analysis
A detailed description of the statistical methods used for model creation and validation can be found in the Appendix. A hold-out sample of 1,000 random observations (41 SSIs) was excluded from the following regression models for later use for validation of our final prediction model. Simple logistic regression models were created for all potential predictors to determine the unadjusted association with SSI. All medical diagnoses were noted on or before the day of admission for total joint arthroplasty. A multivariate logistic regression model was then created (model 1) to create the risk-assessment score (see Appendix). A point scoring system was then created on the basis of the final b coefficients for model 1; points were assigned by dividing the respective coefficients for each predictor by the smallest coefficient in model 1 (diabetes, b = 0.183) and rounding to the nearest half-point. The resulting risk score was determined as the sum of the individual point values, for a possible score ranging from 0 to 35. A model with the risk score as the single predictor was then created (model 2). The discriminatory capability of model 1 and model 2 was assessed by receiver operating characteristic (ROC) curve analysis; goodness of fit was assessed by the Hosmer-Lemeshow (H-L) chisquare test. Finally, the risk-assessment score was validated using the holdout sample of 1,000 observations.
Results
Descriptive Statistics
T he sample had good representation of SSIs (n = 240; 3.5% of the total patient cohort) and uninfected controls (n = 6,549; 
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96.5%) ( Table I ). 1528
The resulting SSI risk score corresponding to the multivariate model was calculated as the point sum for the planned procedure and all present comorbidities, with a possible score ranging from 0 to 35. For each additional point in the SSI risk score, the estimated odds of SSI increased 1.43-fold (95% CI, 1.38 to 1.51-fold) (Table III) . For example, a non-insulindependent patient with diabetes (1 point) and COPD (1 point) who is to undergo a primary total knee arthroplasty (1 point) would have a total SSI risk score of 3 points (Table III) and an estimated probability of SSI of 2.8% (Table IV) .
The multiple logistic regression model (model 1) had good discriminatory capability (area under the ROC curve = 0.7734), as did the SSI risk score based on the multivariate model (model 2) (area under the curve = 0.7699) (Fig. 1) . The multiple logistic regression model (model 1) was well-calibrated (meaning that it fit the data well across varying levels of SSI risk) (H-L chi-square, 10.68; degrees of freedom [df] = 9; p = 0.30), as was the SSI risk score (model 2) (H-L chi-square, 10.12; df = 9; p = 0.34). When varying the cutoff used to predict SSI, a moderately elevated score such as 6.5 demonstrated 37.7% sensitivity and 94.1% specificity for SSI, whereas a high-risk score such as 10 demonstrated a high level of specificity for SSI (99.4%) but not sensitivity (14.1%) (Table V) . Finally, validation of the SSI risk score using the 1,000-patient random hold-out sample demonstrated that it maintained good discriminatory capability (area under the curve = 0.7215) and calibration (H-L chi-square, 9.31; df = 9; p = 0.41).
On the basis of the risk score, most patients had a relatively low estimated risk of SSI, and a small but notable subset of patients was at markedly elevated risk (Figs. 2-A and 2 -B and ROC curve analysis of the multivariate prediction models. The discriminatory capability was similar between model 1, based on the original regression coefficients (area under the curve = 0.7734) ( Fig. 1-A) , and model 2, based on the SSI risk score (area under the curve = 0.7699) ( Fig. 1-B) .
Table VI). A total of 4.8% of the patients who underwent a primary arthroplasty had a risk score of ‡6 points (infection risk rate of ‡7.8%) and accounted for 24% of all SSIs following a primary arthroplasty procedure. A total of 8.3% of the patients who underwent a revision arthroplasty had a risk score of ‡9 points (infection risk rate of ‡20.1%) and accounted for 42% of all SSIs following a revision procedure. The utilization of a 6-point cutoff for primary arthroplasties and a 9-point cutoff for revisions would have resulted in the denial of 5.4% of the surgeries and a reduction of 30.8% of SSIs overall.
Discussion
S ince the advent of total joint arthroplasty, improvements in surgical technique and the use of such prophylactic measures as perioperative antibiotics have drastically reduced SSI rates. However, with increasing yearly volumes of total joint arthroplasty in the United States, there remains a substantial population of patients who have infection-related complications following these procedures. Accurate preoperative infection-risk stratification is an important step toward further reducing SSI rates. We successfully created and validated a simple preoperative SSI risk scoring system for knee and hip arthroplasty with a large and diverse sample of patients from a single academic medical center. We believe that this represents a major advancement from earlier, qualitative methods of determining host susceptibility to orthopaedic infections, such as the Cierny-Mader classification system 9 . We believe that the SSI risk score developed in this study can be utilized to identify high-risk patients and allow the surgeon to provide appropriate counseling for risk modification or nonoperative treatment. In our study, primary arthroplasty patients with a risk score of ‡6 and revision patients with a score of ‡9 represented 5.4% of all procedures but 30.8% of SSIs. There are certainly clinical situations in which high infection risk may be acceptable for total joint arthroplasty, but the use of a cutoff such as 6 points for primary arthroplasty and 9 for revision may be appropriate to cue clinicians to thoroughly discuss with patient the risks of surgery, possible nonsurgical alternatives, and especially, possible means of risk reduction. A logical extension of the current study is to implement this tool in clinical practice to determine its impact on preoperative risk counseling and institutional SSI rates. Additionally, patient comorbidities that are potentially modifiable (such as obesity) represented a substantial portion of our riskassessment models. Treatment of some SSI risk factors, such as Staphylococcus colonization, are considered a standard of care 26 , while policies to address other potentially modifiable factors in our model, such as the requirement of smoking cessation, occur inconsistently in current clinical practice. It is unknown whether risk-factor modification would result in an actual reduction in SSI rates; additional research is therefore indicated.
The current literature regarding total joint arthroplastyrelated infection relies primarily on data from single institutions or general implant registries, often resulting in insufficient data sets for broad data mining and the creation of a robust total joint arthroplasty-specific model of infection prediction. Use of a premature end point for tracking SSI outcomes will result in the misclassification of patients with eventual SSI as healthy controls and will considerably diminish the predictive value of a riskassessment calculator based on these data. Even high-quality national data sets such as the U.S. National Surgical Quality Improvement Program (NSQIP) data set have limited utility for predicting infection risk in the setting of total joint arthroplasty, as this program only follows patients 1 month after surgery. The SSI risk score developed in the current study was based on comprehensive medical records data for a large sample and the identification of SSIs up to 1 year after surgery, which proved to minimize misclassification, as 52.9% of the SSIs were not confirmed until >30 days after joint replacement surgery.
There is strong evidence in the literature that the relationship between SSI risk and the comorbidities included in Distribution of patients by percent infection risk. In our sample, 71% of the patients had a <3.2% infection risk. A small but notable proportion of the sample had a high infection risk; 5.9% of the sample had a >10% infection risk.
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our model is biologically plausible. A relationship between SSI and morbid obesity (a BMI of ‡40 kg/m 2 ) 2, 10, 14, 19, 20, 27 or diabetes 2, 11, 12, 14, 18, 27 has consistently been reported; although both conditions are often concurrent, the current study as well as the results of other multivariate analyses demonstrated that both diabetes and morbid obesity independently contribute to SSI risk 14, 27, 28 . Tobacco abuse 14 , inflammatory arthropathy 15 , primary bone malignancy 12, 14 , and prior lower-extremity fracture [29] [30] [31] [32] are all previously reported SSI risk factors. A history of total joint arthroplasty-related SSI is a known risk factor for repeat SSI, even after delayed surgery 12, 16 ; our results suggest that the risk of repeat SSI remains elevated at least 3 years after a diagnosis of periprosthetic infection or inflammatory response, even for remote-site surgeries (for example, primary left total knee arthroplasty in a patient with a history of right total hip arthroplasty SSI 2 years prior). Although lower-extremity osteomyelitis or septic arthritis may be clinically resolved, the association between these conditions and SSI risk appears to be permanent. Similarly, a history of staphylococcal septicemia, regardless of etiology, had a durable association with SSI in the present study. Additional research is warranted to determine the physiologic basis for the lasting association of prior staphylococcal septicemia, lower-extremity musculoskeletal infection, or inflammatory or infectious complication after total joint arthroplasty with future total joint arthroplasty SSI risk.
One limitation of our SSI risk score is the inability to incorporate several likely risk factors because of limitations in medical coding; for example, no coding distinction is made between a standard and oncologic prosthesis for total joint replacement, although high infection rates have been reported following use of megaprostheses 33 . The SSI risk score was constructed from data from 1 surgery per patient and may underestimate the infection risk in established patients in a clinical practice who require multiple revisions or who present for subsequent primary arthroplasties in different joints. Institutional SSI rates frequently rely on same-hospital readmission data and often fail to capture patients who present to another hospital for treatment. Although our status as a tertiary referral center allows for a high rate of follow-up for patients with SSI who have undergone total joint arthroplasty within our hospital system, this remains a limitation of any single-institution SSI surveillance system.
In conclusion, we believe that the risk of SSI following primary or revision knee and hip arthroplasty can be reliably estimated in a preoperative setting. A prediction tool for SSI within 1 year following primary or revision knee or hip arthroplasty was created and validated with a large, diverse sample of patients from a single academic medical center. The resulting SSI risk score is a point system based on the planned procedure and the presence or absence of 12 medical comorbidities, with a resulting score of 0 to 35. This preoperative risk score relies on readily obtainable clinical information and addresses an important barrier to reducing SSI rates.
